The share price of Atlas Arteria Group (ASX: ALX) is being driven lower after the toll road business announced its FY20 result.
Atlas Arteria is a global owner, operator and developer of toll roads. It has operations in France, the US and Germany.
FY20 result
The toll road business reported that its underlying net profit after tax fell by 61% to $69.6 million. However, the statutory net loss after tax declined 468% to $55.8 million due to a number of notable items.
Those items included a $143.9 million impairment of the Dulles Greenway, a $13.8 million non-cash foreign exchange gain and a final management fee of $2.1 million paid to Macquarie Group Ltd (ASX: MQG).
The France APRR toll road group total traffic (in vehicle kilometres travelled terms) saw a decline of 21% to 19,413 million during the year. APRR toll revenue fell 17.1% to €2.1 billion, earnings before interest, tax, depreciation and amortisation (EBITDA) fell 20.2% to €1.55 billion and net profit declined 28.2% to €628.3 million.
The Warnow Tunnel saw a 7.7% drop in total traffic to 4.56 million. Toll revenue fell 6.5% to €12.7 million and EBITDA dropped 11.6% to €9.1 million.
In the US, the Dulles Greenway saw a 42.7% drop in total traffic to 10.2 million. Toll revenue declined 42.3% to US$51.6 million and EBITDA sank 47.9% to US$38.4 million.
Atlas Arteria said that traffic in all jurisdictions was impacted by COVID-19 movement restrictions but recovered strongly in Europe as restrictions eased, while traffic at Dulles Greenway remained subdued.
Distribution
After paying a $0.11 per security distribution for the first half of FY20, it has given guidance of $0.13 per security for the second half of FY20.
Strategic objectives
The business said that it successfully increased its ownership interest in APRR from 25% to just over 31%, increasing the share of profits and enhancing the governance rights.
Atlas Arteria also said that it has reached contractual close for a new capital structure at the Warnow Tunnel in February 2021, which diversifies the sources of cashflow. Management said that the new arrangements are more capable of supporting the ongoing success of the business and allow for an optimised cash management strategy, resulting in the company having the ability to distribute free cash to Atlas Arteria, rather than being “swept” to lenders.
It also opened up the US market as a future source of institutional capital through a buyback of US retail securityholders.
Atlas Arteria share price movements
Atlas Arteria shares have been sliding in recent times. After almost reaching $7 in November 2020, the Atlas Arteria share price has dropped 20% since then.
Commentary from the CEO
Atlas Arteria CEO Graeme Bevans spoke of the business’ financial position for whatever comes next:
Although we are still in uncertain times, Atlas Arteria’s balance sheet is very well positioned. Our corporate costs will be higher in 2021 with increases in insurance costs a particular driver and some investment in capability to unlock value from our existing businesses. We currently have no corporate debt, ample liquidity, strong cash flows from APRR and Warnow Tunnel and are well placed to face the uncertainties of 2021 and pursue growth opportunities as they arise.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of February 15th 2021
More reading
- Why the a2 Milk (ASX:A2M) share price is crashing 20% to a multi-year low
- Up 230%! What’s going on with the Peppermint Innovation (ASX:PIL) share price?
- The Regis Resources (ASX:RRL) share price is dropping 6%. Here’s why
- The Bravura (ASX:BVS) share price is rocketing after its latest results
- ASX 200 up 0.85%: A2 Milk & Zip shares hammered, Afterpay to raise $1.25bn
Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
The post Atlas Arteria (ASX:ALX) share price driven lower by FY20 report appeared first on The Motley Fool Australia.
from The Motley Fool Australia https://ift.tt/3uu0uSy
Leave a Reply